Related Experiment Video
Updated: May 24, 2026
06:07
Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
Published on: December 17, 2021
Osmotic micropumps for drug delivery
Simon Herrlich1, Sven Spieth, Stephan Messner
1HSG-IMIT - Institut für Mikro- und Informationstechnik der Hahn-Schickard-Gesellschaft e.V., Wilhelm-Schickard-Str. 10, 78052 Villingen-Schwenningen, Germany.
Advanced Drug Delivery Reviews
|February 29, 2012
Summary
Osmotic micropumps offer miniaturized, energy-free drug delivery with constant release rates, overcoming limitations of traditional tablets for long-term parenteral therapies.
Area of Science:
- Biomedical Engineering
- Pharmaceutics
- Drug Delivery Systems
Background:
- Traditional oral drug delivery faces challenges like variable absorption and first-pass metabolism.
- Miniaturized drug delivery systems are needed for precise and sustained therapeutic effects.
- Osmotic principles offer a passive mechanism for controlled fluid movement and drug release.
Purpose of the Study:
- To review miniaturized drug delivery systems utilizing osmotic principles for pumping.
- To explore the design, classification, and applications of osmotic micropumps.
- To highlight the advantages of osmotic pumps over conventional drug delivery methods.
Main Methods:
- Review of scientific literature on osmotic micropump technology.
- Categorization of osmotic pumps based on their structural components (osmotic agent, solvent, drug).
- Discussion of parenteral administration routes and therapeutic applications.
Main Results:
- Osmotic micropumps require no external energy, enabling ultra-small device sizes.
- These pumps achieve constant (zero-order) drug release kinetics.
- Systems are suitable for long-term parenteral administration, bypassing gastrointestinal limitations.
Conclusions:
- Osmotic micropumps represent a significant advancement in miniaturized drug delivery.
- Their ability to provide zero-order release and site-specific or systemic delivery is highly advantageous.
- Further development and application in various therapies are anticipated.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...